Topoisomerase inhibitors strongly downregulate MYC through binding the promoter G-quadruplex Aug. 7, 2019
Oncternal opens enrollment in phase II portion of CIRLL study of cirmtuzumab plus ibrutinib Aug. 7, 2019
RSS